Nuo Therapeutics, Inc. (AURX) income statement
AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026Market cap $60.99MP/E –Yield –
Nuo Therapeutics, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 64.1%
- Operating margin
- -33.3%
- Net margin
- -38.7%
- Return on equity, FY2025
- 1134.6%
Financial strength
- Current ratio
- 1.28
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 28.9%
Valuation
- P/E ratio
- –
- Price to sales
- 11.73
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?